GUARDANT HEALTH, INC. (GH) Scorecard
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
50/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 7 wins, 5 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinGH / S&P 62.42% / 15.20% |
WinGH / S&P 42.74% / 15.00% |
LoseGH / S&P 4.18% / 50.40% |
| 2026-Q11/3 |
LoseGH / S&P -9.57% / -4.33% |
WinGH / S&P 39.56% / 11.30% |
LoseGH / S&P 0.00% / 27.70% |
| 2025-Q42/3 |
WinGH / S&P 63.48% / 2.65% |
WinGH / S&P 32.88% / 9.00% |
LoseGH / S&P -7.02% / 13.40% |
| 2025-Q32/3 |
WinGH / S&P 20.06% / 8.12% |
WinGH / S&P 30.38% / 4.61% |
LoseGH / S&P -25.00% / 13.45% |
| 2025-Q22/3 |
WinGH / S&P 22.16% / 10.94% |
WinGH / S&P 28.74% / 4.83% |
LoseGH / S&P -18.89% / 10.63% |
| 2025-Q12/3 |
WinGH / S&P 39.44% / -4.27% |
WinGH / S&P 28.20% / 4.98% |
LoseGH / S&P -14.39% / 10.57% |
| 2024-Q42/3 |
WinGH / S&P 33.17% / 2.41% |
WinGH / S&P 31.04% / 5.25% |
LoseGH / S&P -17.59% / 6.15% |
| 2024-Q31/3 |
LoseGH / S&P -20.57% / 5.89% |
WinGH / S&P 29.20% / 5.89% |
LoseGH / S&P 5.16% / 6.11% |
| 2024-Q22/3 |
WinGH / S&P 39.99% / 4.28% |
WinGH / S&P 26.20% / 5.38% |
LoseGH / S&P -16.06% / 5.12% |
| 2024-Q11/3 |
LoseGH / S&P -23.73% / 10.56% |
WinGH / S&P 25.21% / 5.71% |
LoseGH / S&P -39.08% / 5.59% |
| 2023-Q41/3 |
LoseGH / S&P -8.74% / 11.69% |
WinGH / S&P 25.45% / 6.81% |
LoseGH / S&P -32.61% / 7.78% |
| 2023-Q31/3 |
LoseGH / S&P -17.21% / -3.27% |
WinGH / S&P 24.38% / 7.52% |
LoseGH / S&P -31.37% / -5.03% |
| 2023-Q22/3 |
WinGH / S&P 52.73% / 8.74% |
WinGH / S&P 25.00% / 9.50% |
LoseGH / S&P -9.06% / -8.57% |
| 2023-Q12/3 |
LoseGH / S&P -13.82% / 7.50% |
WinGH / S&P 23.29% / 10.77% |
WinGH / S&P 57.77% / -15.69% |
| 2022-Q42/3 |
LoseGH / S&P -49.47% / 7.56% |
WinGH / S&P 20.31% / 11.88% |
WinGH / S&P 60.25% / -17.99% |
| 2022-Q33/3 |
WinGH / S&P 33.44% / -4.88% |
WinGH / S&P 25.27% / 13.47% |
WinGH / S&P 46.42% / -1.41% |
| 2022-Q22/3 |
LoseGH / S&P -39.10% / -16.10% |
WinGH / S&P 26.10% / 13.71% |
WinGH / S&P 43.50% / 11.04% |
| 2022-Q11/3 |
LoseGH / S&P -33.77% / -4.60% |
WinGH / S&P 31.29% / 15.97% |
LoseGH / S&P 21.89% / 42.23% |
| 2021-Q41/3 |
LoseGH / S&P -19.99% / 11.03% |
WinGH / S&P 30.32% / 15.00% |
LoseGH / S&P GH unavailable / 96.40% |
| 2021-Q32/3 |
WinGH / S&P 0.66% / 0.58% |
WinGH / S&P 26.74% / 10.77% |
LoseGH / S&P GH unavailable / 69.42% |
| 2021-Q21/3 |
LoseGH / S&P -18.64% / 8.55% |
WinGH / S&P 25.65% / 6.58% |
LoseGH / S&P GH unavailable / 51.81% |
| 2021-Q12/3 |
WinGH / S&P 18.44% / 6.17% |
WinGH / S&P 21.47% / -1.06% |
LoseGH / S&P GH unavailable / 7.39% |
| 2020-Q42/3 |
WinGH / S&P 15.30% / 12.15% |
WinGH / S&P 33.75% / -3.72% |
LoseGH / S&P GH unavailable / -33.42% |
| 2020-Q32/3 |
WinGH / S&P 37.78% / 8.93% |
WinGH / S&P 47.17% / -2.04% |
LoseGH / S&P GH unavailable / -27.10% |
| 2020-Q21/3 |
LoseGH / S&P 16.57% / 20.54% |
WinGH / S&P 77.41% / -0.46% |
LoseGH / S&P GH unavailable / -27.11% |
| 2020-Q12/3 |
WinGH / S&P -10.93% / -19.60% |
WinGH / S&P 121.72% / 3.47% |
LoseGH / S&P GH unavailable / -14.75% |
| 2019-Q42/3 |
WinGH / S&P 22.42% / 9.07% |
WinGH / S&P 136.52% / 5.36% |
LoseGH / S&P GH unavailable / 2.99% |
| 2019-Q31/3 |
LoseGH / S&P -26.06% / 1.70% |
WinGH / S&P 137.05% / 5.02% |
LoseGH / S&P GH unavailable / 0.21% |
| 2019-Q22/3 |
WinGH / S&P 12.56% / 4.30% |
WinGH / S&P 116.04% / 6.64% |
LoseGH / S&P GH unavailable / 8.65% |
| 2019-Q11/3 |
WinGH / S&P 104.04% / 13.65% |
LoseGH / S&P GH unavailable / 8.12% |
LoseGH / S&P GH unavailable / 14.29% |
| 2018-Q40/3 |
LoseGH / S&P GH unavailable / -13.52% |
LoseGH / S&P GH unavailable / 9.05% |
LoseGH / S&P GH unavailable / 18.23% |
| 2018-Q30/3 |
LoseGH / S&P GH unavailable / 7.71% |
LoseGH / S&P GH unavailable / 10.21% |
LoseGH / S&P GH unavailable / 19.06% |
| 2018-Q20/3 |
LoseGH / S&P GH unavailable / 3.43% |
LoseGH / S&P GH unavailable / 9.03% |
LoseGH / S&P GH unavailable / 14.46% |
| 2018-Q10/3 |
LoseGH / S&P GH unavailable / -0.76% |
LoseGH / S&P GH unavailable / 7.68% |
LoseGH / S&P GH unavailable / 12.46% |
| 2017-Q40/3 |
LoseGH / S&P GH unavailable / 6.64% |
LoseGH / S&P GH unavailable / 7.03% |
LoseGH / S&P GH unavailable / 13.82% |
| 2017-Q30/3 |
LoseGH / S&P GH unavailable / 4.48% |
LoseGH / S&P GH unavailable / 5.68% |
LoseGH / S&P GH unavailable / 17.57% |
| 2017-Q20/3 |
LoseGH / S&P GH unavailable / 3.09% |
LoseGH / S&P GH unavailable / 4.83% |
LoseGH / S&P GH unavailable / 17.74% |
| 2017-Q10/3 |
LoseGH / S&P GH unavailable / 6.07% |
LoseGH / S&P GH unavailable / 3.67% |
LoseGH / S&P GH unavailable / 13.32% |
| 2016-Q40/3 |
LoseGH / S&P GH unavailable / 3.82% |
LoseGH / S&P GH unavailable / 2.09% |
LoseGH / S&P GH unavailable / 7.05% |
| 2016-Q30/3 |
LoseGH / S&P GH unavailable / 3.85% |
LoseGH / S&P GH unavailable / 0.20% |
LoseGH / S&P GH unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | GH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 149.96% | 20.78% |
| Annualized return | 149.96% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | GH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 28.14% | 83.14% |
| Annualized return | 5.08% | 12.86% |
10Y · 2018-10-04 to 2026-08-27
| Metric | GH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 423.35% | 319.30% |
| Annualized return | 18.00% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |